Isabel Y. Pappworth
Newcastle Upon Tyne, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Properdin deficiency or anti-properdin treatment ameliorates disease in the C3 gain-of-function mouse model of atypical haemolytic uraemic syndrome.
Journal: Frontiers in immunology
Published: March 11, 2026
Biallelic pathogenic variants in EXOSC3 mediate renal thrombotic microangiopathy of the kidney.
Journal: Kidney international
Published: February 10, 2026
Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy.
Journal: Cancers
Published: July 26, 2022
Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice.
Journal: Frontiers in immunology
Published: August 03, 2021
Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.
Journal: Frontiers in immunology
Published: March 15, 2021
C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: January 09, 2021
Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice.
Journal: The Journal of clinical investigation
Published: December 15, 2017
Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.
Journal: Immunobiology
Published: September 10, 2015
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy.
Journal: Kidney international
Published: March 06, 2015
Last Updated: 09/26/2026